✦ LIBER ✦

Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease

✍ Scribed by Dr M. Flint Beal; Michael F. Mazurek; Clive N. Svendsen; Edward D. Bird; Joseph B. Martin

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 706 KB
Volume: 20
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410200408

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuropeptide Y immunoreactivity is reduc

Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease

✍ Dr M. Flint Beal; Michael F. Mazurek; Geetinder K. Chattha; Clive N. Svendsen; E 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 670 KB

Initial development of ?-aminobutyric ac

Initial development of ?-aminobutyric acid immunoreactivity in the human cerebral cortex

✍ Zecevic, N.; Milosevic, A. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

The development of cortical cells immunoreactive for g-aminobutyric acid (GABA) was studied in human cerebral cortex in the first trimester of gestation (from 4 to 13 gestational weeks; g.w.). The first GABA-immunoreactive (IR) cells were observed at 6.5 g.w., i.e., before the appearance of the cort

Sparse colocalization of somatostatin- a

Sparse colocalization of somatostatin- and GABA-immunoreactivity in the entorhinal cortex of the rat

✍ Floris G. Wouterlood; Helen Pothuizen 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 1022 KB

We studied the regional and laminar distribution of neurons expressing immunoreactivity with antibodies against the neuropeptide somatostatin (SOM) in the entorhinal cortex of colchicine-treated rats. We further determined whether these neurons also express immunoreactivity with antibodies against t

Prevalence of amyloid-β deposition in th

Prevalence of amyloid-β deposition in the cerebral cortex in Parkinson's disease

✍ Frank L. Mastaglia; Russell D. Johnsen; Michelle L. Byrnes; Byron A. Kakulas 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

## Abstract The pathological basis for the dementia which occurs in 20 to 40% of patients with idiopathic Parkinson's disease (PD) remains uncertain. In the present postmortem study, we compared the prevalence and severity of parenchymal and vascular amyloid‐β (Aβ) deposition in the cerebral cortex

Quantitative assessment of synaptic dens

Quantitative assessment of synaptic density in the entorhinal cortex in Alzheimer's disease

✍ Dr. Stephen W. Scheff; D. Larry Sparks; Douglas A. Price 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 776 KB

Galanin immunoreactivity is increased in

Galanin immunoreactivity is increased in the nucleus basalis of meynert in Alzheimer's disease

✍ Dr M. Flint Beal; Usha MacGarvey; Kenton J. Swartz 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

## Abstract A depletion of large cholinergic neurons in the nucleus basalis of Meynert is a consistent finding in Alzheimer's disease (AD). The nucleus basalis of Meynert also contains interneurons and afferents that may modulate its functioning. In the present study we examined neurochemical marke